LINC02182

Across TCGA pan-cancer cohorts, LINC02182 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02182 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC02182 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02182 expression acts as an unfavorable survival marker, although some lineages such as KIRP and THYM show a favorable association.

KIRP, STAD, and UCEC are the cancer types where LINC02182 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Quartile	All	0.948	0.746	<.001	103	view →
STAD	OS	Median	All	0.363	0.747	.003	64	view →
UCEC	OS	Tertile	All	0.888	0.936	.013	38	view →
THYM	DFS	Tertile	All	0.948	0.634	.001	30	view →
TGCT	DFS	Median	All	0.560	0.793	.005	20	view →
KIRC	DFS	Median	IV	0.779	0.404	.001	18	view →
PCPG	DFS	Median	All	0.963	0.798	<.001	16	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	12	view →
ACC	OS	Median	IV	0.842	0.244	.001	12	view →
LGG	OS	Quartile	All	0.822	0.905	.009	10	view →
READ	OS	Tertile	IV	0.927	0.565	.008	9	view →
LIHC	DFS	Quartile	All	0.325	0.476	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02182–KIRP (OS)

Open the KIRP breakdown →